Vapotherm
Exeter
About Vapotherm
Vapotherm is specializing in the development, manufacture, and marketing of respiratory devices that improve clinical outcomes, reduce overall delivery costs, and improve quality of life for patients. The company's breakthrough technology centers on the benefits of high flow delivery of breathing gases through a patented process for heating and humidification. Vapotherm high velocity therapy has been shown to provide proven, comfortable respiratory support without the use of a mask. High Velocity Therapy is a method of rethinking ventilatory support while keeping patient comfort and compliance in mind.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $276.6M
- Funding stage: M&A
- Last round: Post-IPO Equity (Feb 2023)
- Ticker: otcqx:VAPO
- Website: vapotherm.com
- Phone: 866-410-9986
Industries & Categories
Biotechnology, Health Care, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/vapotherm-89817 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.